title: Optimal Use of Beta-Blockers for Congestive Heart Failure.
abstract: Beta-blockers are the cornerstone treatment for congestive heart failure (HF). Current HF guidelines commonly recommend β-blockers for the treatment of HF with reduced left ventricular ejection fraction (LVEF). The effect of β-blockers, however, is less clear for HF patients with preserved LVEF, unstable severe acute HF, or right ventricular failure. This review summarizes the effect of β-blockers in various clinical situations and suggests a strategy for optimal use. (Circ J 2016; 80: 565-571).
authors.affiliation: Internal Medicine, Seoul National University Hospital.
authors.forename: Hae-Young
authors.initials: HY
authors.lastname: Lee
authors.forename: Sang Hong
authors.initials: SH
authors.lastname: Baek
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D013318:Stroke Volume
chemical_list: D000319:Adrenergic beta-Antagonists